Showing 1 - 7 results of 7 for search 'Marleen M. van Loenen', query time: 0.03s Refine Results
  1. 1
    Extracellular domains of CD8α and CD8ß subunits are sufficient for HLA class I restricted helper functions of TCR-engineered CD4(+) T cells.

    Extracellular domains of CD8α and CD8ß subunits are sufficient for HLA class I restricted helper functions of TCR-engineered CD4(+) T cells. by Marleen M van Loenen, Renate S Hagedoorn, Renate de Boer, J H Frederik Falkenburg, Mirjam H M Heemskerk

    Published 2013-01-01
    Get full text
    Article
  2. 2
    A Good Manufacturing Practice procedure to engineer donor virus-specific T cells into potent anti-leukemic effector cells

    A Good Manufacturing Practice procedure to engineer donor virus-specific T cells into potent anti-leukemic effector cells by Marleen M. van Loenen, Renate de Boer, Ellis van Liempt, Pauline Meij, Inge Jedema, J.H. Frederik Falkenburg, Mirjam H.M. Heemskerk

    Published 2014-04-01
    Get full text
    Article
  3. 3
    Optimization of the HA-1-specific T-cell receptor for gene therapy of hematologic malignancies

    Optimization of the HA-1-specific T-cell receptor for gene therapy of hematologic malignancies by Marleen M. van Loenen, Renate de Boer, Renate S. Hagedoorn, Esther H.M. van Egmond, J.H. Frederik Falkenburg, Mirjam H.M. Heemskerk

    Published 2011-03-01
    Get full text
    Article
  4. 4
    T cell receptor engineering of primary NK cells to therapeutically target tumors and tumor immune evasion

    T cell receptor engineering of primary NK cells to therapeutically target tumors and tumor immune evasion by Miranda H Meeuwsen, Laura T Morton, Tassilo L A Wachsmann, Anne K Wouters, Dennis F G Remst, Marleen M van Loenen, J H Frederik Falkenburg, Mirjam H M Heemskerk

    Published 2022-03-01
    Get full text
    Article
  5. 5
    Tertiary lymphoid structure-related immune infiltrates in NSCLC tumor lesions correlate with low tumor-reactivity of TIL products

    Tertiary lymphoid structure-related immune infiltrates in NSCLC tumor lesions correlate with low tumor-reactivity of TIL products by Suzanne M. Castenmiller, Nandhini Kanagasabesan, Aurélie Guislain, Benoît P. Nicolet, Marleen M. van Loenen, Kim Monkhorst, Alexander A.F.A. Veenhof, Egbert F. Smit, Koen J. Hartemink, John B.A.G. Haanen, Rosa de Groot, Monika C. Wolkers

    Published 2024-12-01
    Get full text
    Article
  6. 6
    HA-1H T-Cell Receptor Gene Transfer to Redirect Virus-Specific T Cells for Treatment of Hematological Malignancies After Allogeneic Stem Cell Transplantation: A Phase 1 Clinical Study

    HA-1H T-Cell Receptor Gene Transfer to Redirect Virus-Specific T Cells for Treatment of Hematological Malignancies After Allogeneic Stem Cell Transplantation: A Phase 1 Clinical St... by Peter van Balen, Inge Jedema, Marleen M. van Loenen, Renate de Boer, H. M. van Egmond, Renate S. Hagedoorn, Conny Hoogstaten, Sabrina A. J. Veld, Lois Hageman, P. A. G. van Liempt, Jaap-Jan Zwaginga, Jaap-Jan Zwaginga, Pauline Meij, H. Veelken, J. H. F. Falkenburg, Mirjam H. M. Heemskerk

    Published 2020-08-01
    Get full text
    Article
  7. 7
    Polyfunctional tumor-reactive T cells are effectively expanded from non-small cell lung cancers, and correlate with an immune-engaged T cell profile

    Polyfunctional tumor-reactive T cells are effectively expanded from non-small cell lung cancers, and correlate with an immune-engaged T cell profile by Rosa De Groot, Marleen M. Van Loenen, Aurélie Guislain, Benoît P. Nicolet, Julian J. Freen-Van Heeren, Onno J.H.M. Verhagen, Michel M. Van Den Heuvel, Jeroen De Jong, Patrick Burger, C.Ellen Van Der Schoot, Robbert M. Spaapen, Derk Amsen, John B. A. G. Haanen, Kim Monkhorst, Koen J. Hartemink, Monika C. Wolkers

    Published 2019-11-01
    Get full text
    Article

Search Tools: